Positive ARTISTRY-2 Trial Results for BIC LEN H...

By HEOR Staff Writer

December 17, 2025

BIC/LEN HIV Regimen Delivers Non-Inferior Results in ARTISTRY-2 Gilead Sciences announced positive topline results from the Phase 3 ARTISTRY-2 trial, demonstrating that ...
Accelerating Tec-Dara Multiple Myeloma Therapy Review: A Game Changer for Pat...
CHMP Meeting Highlights: December 2025 Advances in New Medicines Approvals
AKEEGA BRCA2 Approval: Landmark FDA Decision for Precision Therapy in Aggress...
Arexvy RSV Vaccine Expansion: Broader Access and Impact on Adult Health Outcomes
Provisional Agreement on EU Pharmaceutical Reform: Boosting Innovation and Co...
2025 China Drug Catalog Boosts Access with 114 New Drugs and Innovative Solut...
NICE Approves Seven Digital Cardiac Rehabilitation Technologies for Enhanced ...
Repurposing Off-Patent Medicines: Insights from the EU Pilot Initiative
Innovations in Haematology Cell Therapy at ASH 2025
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
Advancements in Continuous Glucose Monitoring for Type 2 Diabetes Management
GLP-1RAs Psychiatric Care: Transforming Metabolic Management for Psychotropic...